Bitcoin sets a new all-time high above $6,000 >>> READ MORE

4 Stocks to Watch on Dendreon Earnings

Other smaller companies could move right along with DNDN

      View All  


Click to Enlarge
Market Cap: $65M

Description from Yahoo! Finance

Agenus (NASDAQ:AGEN), a biotechnology company, engages in developing and commercializing technologies to treat cancers and infectious diseases. It offers oncophage vaccine for the treatment of adjuvant renal cell carcinoma.

Click to Enlarge
Technical Analysis

The stock trades both above its 200- and 50-day moving averages and is consolidating above $3. A move above $3.50 could swing the stock much higher while a close below $2 puts the stock in danger of filling at least part of the gap dating back to September 2011 (gray box).

Article printed from InvestorPlace Media,

©2017 InvestorPlace Media, LLC